关于乳腺X线摄影获益与危害的信息对女性决策的影响:一项随机对照试验的研究方案
该研究为两阶段随机对照试验,在西班牙四个乳腺癌筛查项目中选择40个基本健康区域并随机分为干预组和对照组,每组随机选取400名即将达到乳腺X线摄影筛查邀请年龄的女性。干预组接受详细说明筛查获益与危害的宣传单,对照组接受不提危害并建议参加每两年一次筛查的标准宣传单,主要结局为结合知识、态度和意图的知情选择。
要点
- 首个在西班牙评估乳腺X线摄影筛查获益与危害信息对决策影响的随机对照试验。
- 主要结局为知情选择,次要结局包括决策冲突、决策信心、焦虑、担忧、预期后悔等。
- 干预组接受详细说明获益与危害的宣传单,对照组接受不提危害的标准宣传单。
核心结论
- 该研究旨在评估提供筛查获益与危害信息对决策相关结局的影响,并推动西班牙乳腺癌筛查中的共享决策。
研究设计与样本
- 两阶段随机对照试验,第一阶段选择40个基本健康区域并随机分为干预组或对照组,第二阶段在每个基本健康区域内随机选取女性(n=400)。
- 研究纳入西班牙公共卫生系统的四个乳腺癌筛查项目,其中三个在加泰罗尼亚,一个在加那利群岛。
- 主要结局为知情选择,即结合知识、态度和意图的二分类变量;次要结局包括决策冲突、决策信心、筛查参与焦虑、乳腺癌担忧、预期后悔、时间观、筛查获益与危害的感知重要性、感知乳腺癌风险及宣传单可接受性。
- 主要和次要结局在干预后2至3周评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary to inform women so that they can actively participate in decision-making and make an informed choice based on their values and preferences. The objective of this study is to assess the effects of receiving information about the benefits and harms of screening on decision-making, in women approaching the age of invitation to mammography screening. METHODS: A two-stage, randomized controlled trial (RCT). In the first stage, 40 Basic Health Areas (BHAs) will be selected and randomized to intervention or control. In the second stage, women within each BHA will be randomly selected (n = 400). Four breast cancer screening programs (BCSPs) of the Spanish public health system, three in Catalonia and one in the Canary Islands will participate in the study. Women in the intervention arm will receive a leaflet with detailed information on the benefits and harms of screening using mammography. Women in the control arm will receive a standard leaflet that does not mention harms and recommends accepting the invitation to participate in the biennial examinations of the BCSP. The primary outcome is informed choice, a dichotomous variable that combines knowledge, attitudes, and intentions. Secondary outcomes include decisional conflict; confidence in the decision made; anxiety about screening participation; worry about breast cancer; anticipated regret; time perspective; perceived importance of benefits/harms of screening; perceived risk of breast cancer; and leaflet acceptability. Primary and secondary outcomes are assessed 2-3 weeks after the intervention. DISCUSSION: This is the first RCT that assesses the effect of informing about the benefits and harms of breast cancer screening in Spain in women facing the decision to be screened using mammography. It aims to assess the impact of information on several decisional outcomes and to contribute to paving the road towards shared decision-making in breast cancer screening in our country. TRIAL REGISTRATION: ClinicalTrials.gov registry, ID: NCT03046004 . Retrospectively registered on 4 February 2017. Trial name: InforMa study.
引用
- Carles M, Martínez-Alonso M, Pons A, et al. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28899412. doi:10.1186/s13063-017-2161-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。